BullFrog AI Partners with Sygnature Discovery to Expand AI-Driven Drug Discovery Platform Access
BullFrog AI announced a strategic collaboration with UK-based CRO Sygnature Discovery to introduce its AI-driven BullFrog Data Networks™ platform to global biopharma clients.
BullFrog AI Partners with Eleison to Optimize Phase 3 Pancreatic Cancer Trial Using AI Analytics
BullFrog AI and Eleison Pharmaceuticals have formed a strategic collaboration to enhance the Phase 3 clinical trial of glufosfamide for pancreatic cancer using AI-powered analytics.